[ad_1]
Xinhua News Agency, New Delhi, Dec 19, Report: India’s New Crown Confirmed Cases of Over 10 Million Vaccines Faces Multiple Challenges
Xinhua News Agency reporter Zhao Xu
The latest statistics on the new corona epidemic released by the Indian Ministry of Health on the 19th showed that the cumulative number of confirmed cases across the country had exceeded 10 million by morning, making it the second country. after the United States with more than 10 million confirmed cases. Although the spread of the new corona epidemic in India has slowed down, the prevention and control situation remains dire. Furthermore, India still faces multiple challenges to advance the distribution and vaccination of the new corona vaccine.
According to the data, at 9 a.m. local time on the 19, India has a total of 1,0004599 confirmed cases and a total of 145,136 deaths. In the past 24 hours, there were 25,152 new confirmed cases and 347 new deaths.
Previously, India’s growing number of confirmed cases peaked on September 16, at 97,860, and the cumulative number of confirmed cases that day exceeded 5 million. Subsequently, it took 12 days for each additional million cases to rise from 5 million to 6 million, while the most recent increase of 1 million cases took 29 days, indicating that the spread of the epidemic has slowed. In the past week, the number of confirmed cases in India has stabilized at 20,000 to 30,000, a sharp drop from the peak.
The Epidemic Research Committee of the Indian Ministry of Science and Technology recently stated that according to the model developed by the committee, there will be no peak of the epidemic in India in the future. As the number of cases cured per day exceeds the number of recently confirmed cases, the number of existing cases in India is expected to decline steadily to a low level. However, the Indian media believe that the government and the population should not be too optimistic about the current situation of the epidemic. The report quoted committee member Professor Agrawal as saying that ordinary people have little self-discipline to follow the government’s call to wear masks, and that the epidemic has potentially been spreading among the population and causing widespread infections.
The Indian government is also aware of the existence of this problem. In order to effectively control the epidemic, India has stepped up its efforts to improve the detection capabilities of the new corona virus since the end of July. The latest data from the Indian Medical Research Council shows that as of the 18th, the cumulative number of test samples in India exceeded 160 million, and the average daily test capacity basically stabilized at around 1 million.
At present, many countries around the world are successively starting the vaccination work of the new crown. India faces multiple challenges, such as storage and logistics in the distribution and vaccination of the new corona vaccine. According to India’s “Business Standard” report, India could start work on vaccination in January next year. India’s current new corona vaccine production capacity can meet both domestic and export needs, but some analysts noted that the real bottleneck for India’s vaccines is infrastructure storage facilities and capacity cold chain transport. Many Indian media outlets believe that vaccines have very strict requirements for transport and storage conditions and require a strong industrial chain to coordinate and cooperate, involving many fields such as pharmaceutical, logistics and cold storage.
Indian epidemiologist Shahid Jamir said in an interview with local media that the biggest challenge is managing the cold chain. If the new corona vaccine requires storage conditions of minus 20 degrees Celsius to minus 70 degrees Celsius, India has a very limited storage capacity, much less distributed to all parts of the country. He suggested that India should use, as far as possible, vaccines that can be stored and transported between 4 degrees Celsius and 10 degrees Celsius.
Sunil, CEO of India Yeti Logistics, said that currently no company in India has the capacity to transport and store goods with temperatures below minus 40 degrees Celsius. The new corona vaccine developed by Pfizer Pharmaceuticals Co., Ltd. and the German biotech company requires a storage environment of minus 70 degrees Celsius, making transportation difficult. The general demand from India for the new corona vaccine is large and the vaccination area is wide. The distribution and management of the vaccine will be a difficult task.
Source: Xinhua News Agency
